Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of Intracranial Hemorrhage? | Zendy

Amy C. Justice | Zendy; David S. Zingmond | Zendy; Kirsha S. Gordon | Zendy; Shawn L. Fultz | Zendy; Joseph L. Goulet | Zendy; Joseph T. King | Zendy; Dawn M. Bravata | Zendy; Hernán Valdez | Zendy; Michael D. Kraft | Zendy; Kristin Mattocks | Zendy

Open Access

Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of Intracranial Hemorrhage?

Author(s) -

Amy C. Justice,

David S. Zingmond,

Kirsha S. Gordon,

Shawn L. Fultz,

Joseph L. Goulet,

Joseph T. King,

Dawn M. Bravata,

Hernán Valdez,

Michael D. Kraft,

Kristin Mattocks

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/592302

Subject(s) - medicine , comorbidity , food and drug administration , toxicity , drug , pharmacology

The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research